Caplight Directory>Investors>Cenova Capital>Cenova-capital-1


Cenova Capital

Cenova Capital

Shanghai, Shanghaicenovaventures.com

Overview

One the earliest healthcare dedicated funds in China, Cenova Capital was established in 2010 to provide thoughtful and connected capital to transform China's healthcare industry. As a value-oriented investor, Cenova uses a methodical, research-based approach to uncover unique proprietary investment opportunities, and build synergies across its portfolio. Cenova has four funds under management with a combined AUM of over USD600 million invested in over 40 companies in the life sciences and healthcare product and services sectors, including directly or indirectly more than 30 hospitals in Mainland China.

Year Founded

2010

AUM

$600M

Portfolio Companies

17

Investments

CompanyDateStageLead
Accro Bioscience Inc.May 2026Series CCo-investor
Accro Bioscience Inc.May 2026Series CCo-investor
Vivace TherapeuticsMar 2025Series DCo-investor
Eluminex BiosciencesFeb 2023Series BLead
Pulnovo MedicalNov 2022VC RoundCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2010
AUM$600M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.